This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCerebral venous sinus thrombosis (CVST) is a rare form of stroke that usually affects young females especially during pregnancy and the postpartum period.
These results suggest that abelacimab may be safe across the spectrum of bleeding risk and may make it possible to anticoagulate some of the most vulnerable populations who otherwise would not be treated and therefore left unprotected from the risk of stroke. Data from these trials are expected in the second half of 2026.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024. Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited. The most common neurologic reasons for readmission differed by age group, but included headaches, seizures, and stroke.
Stroke, Volume 55, Issue Suppl_1 , Page AWP302-AWP302, February 1, 2024. Background and Objectives:Understanding the mechanisms of thrombosis is crucial for the future advancement in treating ischemic stroke. While many researches on thrombogenesis have been conducted, there was a limited data on thrombus growth. mm3(range 23.8-79.8).
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists. Stroke) A Danish study indicated that combining nitrates and PDE5 inhibitors isn't always a terrible idea for men with ischemic heart disease and erectile dysfunction.
Stroke, Volume 54, Issue 12 , Page 2981-2989, December 1, 2023. BACKGROUND:Cancer is associated with an increased risk of stroke. The composition of thrombi may reflect the mechanism of thrombosis, aiding the determination of the treatment strategy. In both groups, the median age was 65 years, and 12 patients (52.2%) were men.
Stroke, Volume 55, Issue Suppl_1 , Page ATP225-ATP225, February 1, 2024. Background and Purpose:Cancer increases the risk for acute ischemic stroke (AIS) and deep venous thrombosis. The role of paradoxical embolization as a stroke etiology in patients with cancer is uncertain.
Stroke, Volume 56, Issue Suppl_1 , Page AWP291-AWP291, February 1, 2025. Cancer patients are also prone to these complications, but it remains uncertain how the prevalence of medical complications differs between AIS patients with (AIS-C) vs AIS without cancer (AIS-NC).Methods:We
Stroke, Volume 55, Issue Suppl_1 , Page A136-A136, February 1, 2024. Introduction:Active cancer is a known risk factor for cerebral venous thrombosis (CVT), but it is unknown whether CVT is also associated with occult cancer. We calculated the cumulative incidence of cancer after CVT with death as a competing risk.
This can lead to a transient ischemic attack (TIA) or stroke. Deep Vein Thrombosis (DVT) : A blood clot occurring in a deep vein. Causes include infection, malignancy, surgery, scar tissue formation, trauma, deep vein thrombosis (DVT), radiation or other cancer treatment. Damaged valves within the veins cause this.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content